Zobrazeno 1 - 10
of 86
pro vyhledávání: '"C Piwko"'
Publikováno v:
Cancer Research. 73:P4-12
Background Trastuzumab Emtansine (T-DM1) is an antibody–drug conjugate (ADC) comprised of the microtubule inhibitory cytotoxic agent DM1 and trastuzumab which, in addition to its antitumor properties, targets T-DM1 to HER2–overexpressing cells. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36e0e81fdbc0c850a91054f0cbea302b
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-16
https://doi.org/10.1158/0008-5472.sabcs13-p4-12-16
Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 355:168-176
The distribution of somatostatin (SRIF) receptor sites was studied by in vitro receptor autoradiography in the human brain and pituitary using the SRIF1 (sst2) receptor selective [125I]Tyr3-octreotide, the non-subtype selective [125I]LTT-SRIF-28 ([Le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::317327acb811aa7a87479ff545d43997
https://doi.org/10.1007/pl00004928
https://doi.org/10.1007/pl00004928
Publikováno v:
Neuroscience. 75:857-868
In situ hybridization histochemistry with somatostatin sst1-sst5 receptor messenger RNA-selective oligoprobes and quantitative receptor autoradiographic binding studies using [125I]Tyr3-octreotide, [Leu2,D-Trp22,125I-Tyr25]somatostatin-28 and [125I]C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37a714b9df91d2fe403c23136b09674b
https://doi.org/10.1016/0306-4522(96)00304-1
https://doi.org/10.1016/0306-4522(96)00304-1
Somatostatin receptors in the Rhesus monkey brain: localization and pharmacological characterization
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 353:648-660
To characterize the nature and distribution of somatostatin (SRIF) receptors, radioligand binding studies and in vitro receptor autoradiography were performed in Rhesus monkey brain using either [125I]LTT-SRIF-28 ([Leu8, D-Trp22, 125I-Tyr25]SRIF-28)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::873af4c15709587721869b3cf172ead1
https://doi.org/10.1007/bf00167184
https://doi.org/10.1007/bf00167184
Background: Patients having chronic schizophrenia with frequent relapses and hospitalizations represent a great challenge, both clinically and financially. Risperidone long-acting injection (RIS-LAI) has been the main LAI atypical antipsychotic treat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::1ccb37b4796a0f5cd69f4e090abc7113
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111081
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3111081
Publikováno v:
Journal of medical economics. 13(3)
To estimate the cost effectiveness of solifenacin 5 mg/day compared to oxybutynin immediate-release (IR) 15 mg/day in patients with overactive bladder, from the perspective of the Canadian healthcare (payer) system.A Markov model was adapted to estim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7030e19f6bd3d438bb7ba9ac78f3854a
https://pubmed.ncbi.nlm.nih.gov/20690893
https://pubmed.ncbi.nlm.nih.gov/20690893
Publikováno v:
Value in Health. 11(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::749c7b01b8d26939a1a14ace4ce2fb9a
Publikováno v:
Value in Health. 11(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66e86e8f9e82175fa7912353d6d8609d
Publikováno v:
Value in Health. 9(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b70152ca20f3bc1944c2dfa63f1abee
Publikováno v:
Value in Health. 9(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a934eddede5074cc0230a5ac3839f3d